| Name | Title | Contact Details |
|---|
Foresee is a Taiwan and US-based biopharmaceutical company listed on the Taipei Exchange (6576.TWO). Foresee`s R&D efforts are focused in two key areas, namely its unique stabilized injectable formulation (SIF) depot delivery technology with derived drug products targeting specialty markets, and secondly its transformative preclinical and clinical first-in-class NCE programs targeting rare and severe disease areas with high unmet needs. Foresee`s product portfolio includes late stage and early stage programs. CAMCEVI® 42 mg is now approved in the U.S. and under regulatory review in the EU. Additionally, U.S. and EU regulatory submissions are in preparation for CAMCEVI® 21 mg. FP-025 – a highly selective oral MMP-12 inhibitor targeting inflammatory and fibrotic diseases, currently in Phase 2/3 studies, including a Phase 2/3 study for COVID-19 virus-induced acute respiratory distress syndrome (ARDS). FP-045 – a highly selective oral small molecule allosteric activator of ALDH2, a mitochondrial enzyme, for which a Phase 1b/2 study is currently planned for Fanconi Anemia.
Kardia Health is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nightengale Home Healthcare Inc is a Carmel, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tufts Health Care Institute is a Boston, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Headquartered in Austin, we started as a single store with a mission to deliver outstanding results for our customers by providing supplements with the best-in-class ingredients and putting the customer`s experience first. Now more than 10 years later, we have evolved into Defyned Brands, a product development, brand marketing, and multi-channel retail company, owning 5 lifestyle supplement brands and over 50 retail stores under the name 5 Star Nutrition. We are passionate about putting our customers first by helping them reach their health and wellness potential.